Gene: TMEM242
Official Full Name: transmembrane protein 242provided by HGNC
Gene Summary: Involved in mitochondrial proton-transporting ATP synthase complex assembly. Located in mitochondrial inner membrane. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO13183 | TMEM242 Knockout cell line (HeLa) | Human | TMEM242 | 1:3~1:6 | Negative | Online Inquiry |
KO13184 | TMEM242 Knockout cell line (HCT 116) | Human | TMEM242 | 1:2~1:4 | Negative | Online Inquiry |
KO13185 | TMEM242 Knockout cell line (HEK293) | Human | TMEM242 | 1:3~1:6 | Negative | Online Inquiry |
KO13186 | TMEM242 Knockout cell line (A549) | Human | TMEM242 | 1:3~1:4 | Negative | Online Inquiry |
TMEM242 Gene Knockout Cell Lines are genetically engineered cellular models created for the in-depth study of the TMEM242 gene's role in various biological processes and disease mechanisms. Utilizing CRISPR-Cas9 gene editing technology, these cell lines provide a powerful tool for researchers to investigate the functional outcomes of gene deletion in a controlled environment.
The key function of TMEM242 Gene Knockout Cell Lines lies in their ability to eliminate the expression of the TMEM242 protein, allowing for comprehensive analyses of gene function. By studying these knockout models, scientists can elucidate the gene’s involvement in cellular pathways, signal transduction, and iron metabolism, as well as its implications in neurodegenerative diseases and other medical conditions. The precise mechanism of action involves the CRISPR-Cas9 system inducing double-strand breaks in the gene of interest, which are subsequently repaired by error-prone repair pathways, leading to gene disruption.
Scientifically, the TMEM242 Gene Knockout Cell Lines are invaluable in both research and clinical settings. They provide insights for pharmaceutical development, aiding in the identification of potential therapeutic targets through functional assays. These cell lines serve as essential assets for drug screening, providing a relevant biological context to test compound efficacy and safety.
What sets our TMEM242 Gene Knockout Cell Lines apart from traditional models is their high specificity and reliability, coupled with a streamlined use in laboratory applications. Unlike transient knockdown strategies, these stable knockout cell lines eliminate the confounding effects of residual gene expression, ensuring robust experimental outcomes.
For researchers, clinicians, and pharmaceutical developers, these cell lines represent a significant advancement in the exploration of TMEM242-related functions and the development of innovative treatment strategies. By integrating sophisticated genetic tools with user-friendly protocols, our product facilitates groundbreaking discoveries in the life sciences.
Our company specializes in the development of high-quality biological products, informed by cutting-edge research techniques and a commitment to advancing scientific understanding. We aim to support our clients in their quest for innovation while providing expertise tailored to their research needs.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.